Similar trends of poor persistence were seen in other subgroups, with patients with a history of peripheral arterial revascularization, heart failure, PAD, and renal disease at baseline all having greater probability of persistence (although still poor) than those with no history (comparisons did not reach statistical significance; Tables 8 , 9 , 10 and 11 ).
← all excerpts
Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis.
1
—
—